A detailed history of Winton Group LTD transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Winton Group LTD holds 2,337 shares of MEDP stock, worth $814,397. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,337
Previous 1,877 24.51%
Holding current value
$814,397
Previous $773,000 0.78%
% of portfolio
0.06%
Previous 0.06%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$320.58 - $457.29 $147,466 - $210,353
460 Added 24.51%
2,337 $779,000
Q2 2024

Aug 09, 2024

SELL
$372.0 - $424.34 $195,672 - $223,202
-526 Reduced 21.89%
1,877 $773,000
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $195,135 - $283,117
685 Added 39.87%
2,403 $971,000
Q4 2023

Feb 12, 2024

SELL
$227.52 - $312.68 $31,852 - $43,775
-140 Reduced 7.53%
1,718 $526,000
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $2,573 - $3,098
11 Added 0.6%
1,858 $449,000
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $918,510 - $1.18 Million
-4,905 Reduced 72.65%
1,847 $443,000
Q1 2023

May 12, 2023

SELL
$174.31 - $239.52 $5.83 Million - $8.02 Million
-33,463 Reduced 83.21%
6,752 $1.27 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $5.85 Million - $8.66 Million
38,216 Added 1911.76%
40,215 $8.54 Million
Q3 2022

Nov 10, 2022

SELL
$145.13 - $182.49 $1.13 Million - $1.42 Million
-7,765 Reduced 79.53%
1,999 $314,000
Q2 2022

Aug 10, 2022

BUY
$130.2 - $168.03 $199,336 - $257,253
1,531 Added 18.6%
9,764 $1.46 Million
Q1 2022

May 11, 2022

BUY
$138.87 - $214.31 $130,815 - $201,880
942 Added 12.92%
8,233 $1.35 Million
Q4 2021

Feb 10, 2022

BUY
$182.74 - $227.9 $48,974 - $61,077
268 Added 3.82%
7,291 $1.59 Million
Q3 2021

Oct 28, 2021

SELL
$170.18 - $198.21 $186,347 - $217,039
-1,095 Reduced 13.49%
7,023 $1.33 Million
Q2 2021

Aug 10, 2021

BUY
$158.62 - $194.3 $75,820 - $92,875
478 Added 6.26%
8,118 $1.43 Million
Q1 2021

Jul 21, 2021

SELL
$132.02 - $168.26 $279,486 - $356,206
-2,117 Reduced 21.7%
7,640 $1.25 Million
Q4 2020

Feb 12, 2021

SELL
$109.38 - $149.19 $2.04 Million - $2.78 Million
-18,653 Reduced 65.66%
9,757 $1.36 Million
Q3 2020

Oct 30, 2020

SELL
$92.95 - $130.61 $12,176 - $17,109
-131 Reduced 0.46%
28,410 $3.18 Million
Q2 2020

Aug 05, 2020

SELL
$68.08 - $95.68 $2.86 Million - $4.02 Million
-42,010 Reduced 59.55%
28,541 $2.66 Million
Q1 2020

May 11, 2020

SELL
$61.71 - $101.95 $3.35 Million - $5.53 Million
-54,270 Reduced 43.48%
70,551 $5.18 Million
Q4 2019

Feb 13, 2020

BUY
$70.08 - $84.64 $6.22 Million - $7.51 Million
88,783 Added 246.36%
124,821 $10.5 Million
Q3 2019

Nov 08, 2019

BUY
$62.38 - $85.89 $1.51 Million - $2.08 Million
24,162 Added 203.45%
36,038 $3.03 Million
Q2 2019

Jul 08, 2019

BUY
$53.64 - $65.42 $327,257 - $399,127
6,101 Added 105.65%
11,876 $777,000
Q1 2019

May 13, 2019

BUY
$49.38 - $70.58 $285,169 - $407,599
5,775 New
5,775 $341,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.